Five Prime Therapeutics Debt 2024

Five Prime Therapeutics Aktienanalyse

What does Five Prime Therapeutics do?

Five Prime Therapeutics Inc. is a biotech company based in South San Francisco, California. It specializes in the discovery and development of innovative therapeutics for serious diseases. The company was founded in 2001 by leading biotechnology researchers and has undergone several mergers and acquisitions. It is currently listed on the Nasdaq stock exchange under the ticker symbol "FPRX". Five Prime Therapeutics' business model is based on the discovery and development of therapeutics for diseases that have been inadequately treated. The company focuses on precision medicine approaches tailored to the individual needs of patients. Its main areas of focus include cancer therapies, inflammatory diseases, and rare genetic diseases. To achieve these goals, the company utilizes a wide range of therapeutic platforms, including antibodies, biologics, and protein therapies. These platforms are based on a deeper understanding of disease processes and mechanisms, as well as a precise understanding of biological and molecular connections in the human body. Five Prime Therapeutics also utilizes artificial intelligence and machine learning in the development of new therapeutics. The company has four main divisions: oncology, immunology, women's health, and genomics/proteomics. Each division focuses on specific indications and development programs. Some key developments and products in each division include: - Oncology: Five Prime Therapeutics has a broad pipeline of precision oncology therapeutics. One of the most important development programs is "FPA150," an antibody targeting B7-H4, a protein expressed by cancer cells. FPA150 is being tested in clinical studies for the treatment of solid tumors and cervical cancer. - Immunology: The company has also developed a pipeline of immunotherapeutics and biologics targeting the treatment of inflammatory diseases such as rheumatoid arthritis and Crohn's disease. One of the key development programs in this area is "FP-028," which targets the TGF-beta signaling pathway. - Women's Health: Five Prime Therapeutics also has a division focused on women's health. An important development program in this area is "FP-1039/GSK3052230," a biologic that could potentially be used for the treatment of ovarian cancer. - Genomics/Proteomics: As the fourth main division, the company is working on biomarker-based therapeutics targeting specific genetic mutations and signaling pathways. An important component of this work is the identification of new target molecules through genomics and proteomics technologies. Overall, Five Prime Therapeutics has achieved an impressive track record in the discovery and development of innovative therapeutics in recent years. Several of its main programs have successfully entered clinical studies and are showing promising results. Additionally, the company has established a successful partnership with GlaxoSmithKline to jointly develop new therapeutics for the treatment of cancer and inflammatory diseases. In summary, Five Prime Therapeutics is an emerging biotech company specialized in the discovery and development of innovative therapeutics for serious diseases. Through its precision medicine business model and wide range of therapeutic platforms, the company has made successful progress in the development of promising therapeutics. Five Prime Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Five Prime Therapeutics's Debt Structure

Five Prime Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Five Prime Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Five Prime Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Five Prime Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Five Prime Therapeutics Stock

What is the debt of Five Prime Therapeutics this year?

Five Prime Therapeutics has a debt level of 0 USD this year.

What was the debt of Five Prime Therapeutics compared to the previous year?

The debt of Five Prime Therapeutics has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in Five Prime Therapeutics?

High debt can pose a risk for investors of Five Prime Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Five Prime Therapeutics?

Low debt means that Five Prime Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Five Prime Therapeutics affect the company?

An increase in debt of Five Prime Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Five Prime Therapeutics affect the company?

A reduction in debt of Five Prime Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Five Prime Therapeutics?

Some factors that can influence the debt of Five Prime Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Five Prime Therapeutics so important for investors?

The debts of Five Prime Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Five Prime Therapeutics take to change the debt?

To change the debt, Five Prime Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Five Prime Therapeutics pay?

Over the past 12 months, Five Prime Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Five Prime Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Five Prime Therapeutics?

The current dividend yield of Five Prime Therapeutics is .

When does Five Prime Therapeutics pay dividends?

Five Prime Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Five Prime Therapeutics?

Five Prime Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Five Prime Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Five Prime Therapeutics located?

Five Prime Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Five Prime Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Five Prime Therapeutics from 6/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Five Prime Therapeutics pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Five Prime Therapeutics in the year 2023?

In the year 2023, Five Prime Therapeutics distributed 0 USD as dividends.

In which currency does Five Prime Therapeutics pay out the dividend?

The dividends of Five Prime Therapeutics are distributed in USD.